Administration of AVP just prior to conception and chronically throughout gestation in this model thus disrupts maternal physiology in its earliest stages, as many have argued occurs in clinical preeclampsia, and elicits critical, translationally-relevant preeclampsia phenotypes. The gene discussed is AVP; the disease is preeclampsia.